Follow us

Kimberly-Clark completes $48.7bn Kenvue deal, taking ownership of Aveeno and Neutrogena

Camilla Rydzek
04 November 2026

American firm Kimberly-Clark has completed its acquisition of Kenvue, bringing skincare brands Neutrogena and Aveeno into the same group as Kleenex, Huggies and Kotex.

At the time the agreement was first announced, on 3 November 2025, Kenvue was valued at approximately $48.7 billion (£36.1 billion) on an enterprise-value basis.

The combined company counts 10 global billion-dollar brands, including Huggies, Listerine, Neutrogena, Kleenex and Johnson’s Baby, which are all currently trading in the UK.

Kimberly-Clark said the business serves consumers in more than 175 countries, with baby care, women's health and active ageing named as priority categories.

Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark, leads the enlarged group. "With Kenvue, Kimberly-Clark is equipped to combine deep consumer insight, groundbreaking science and innovation, brand-building expertise and strong commercial execution to lead the future of consumer health," he said.

Kimberly-Clark plans to apply its Powering Care growth model to the Kenvue portfolio, with a focus on innovation, brand-building and commercial execution. When the deal was first announced, the companies cited Kenvue's relationships with dermatologists, dentists and paediatricians as a key capability and set out plans for more investment in research and development, quality and innovation.

The company reaffirmed its target of around $2.1 billion (£1.56 billion) in annual financial benefits following the merger. That figure is made up of approximately $1.9 billion (£1.41 billion) in cost savings, expected within three years of completion, and about $500 million (£371 million) in additional profit contributed by revenue synergies within four years. However, around $300 million (£222 million) of reinvestment partly offsets these gains.

The group will operate through four segments, announced in April. Their sizes are based on management estimates of the two companies' combined 2025 net sales, recast for the new structure. North America accounts for approximately $18 billion (£13.35 billion), while Europe, the Middle East and Africa represents around $5 billion (£3.71 billion). Asia Pacific Focus Markets, covering Greater China, Australia and New Zealand, South Korea and Indonesia, brings in roughly $4.3 billion (£3.19 billion). Enterprise Markets, spanning Latin America, India, Southeast Asia and Japan, account for about another $4.3 billion.

Three Kenvue directors have joined Kimberly-Clark's board, which now has 13 members.

In the UK, both of Kenvue's skincare brands have stepped up consumer-facing activity this year. Neutrogena was Official Beauty Partner of The BRIT Awards 2026, while Aveeno launched its Calm+Restore Oat Rich Cream and a new body oil spray at a Skin & Strength Studio pop-up in Soho, which offered dermatologist and trichologist consultations.

Kimberly-Clark had already been edging towards beauty before the deal closed. In September, Kleenex launched a Beauty Tissues range for oil blotting and make-up touch-ups, sold through major UK supermarkets and online retailers.


Free NewsletterVISIT TheIndustry.fashion
cross